PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Wu D. Br J Clin Pharmacol. Jan 1993; 35(1): 30-4 Pubmed, Volltext [3845]
Wu et al. J Chin Med Assoc. 2009 Aug;72(8):446-449 [1928]
Wu H. Clin Ther. Mar 2010; 32(3): 597-606 Pubmed [7272]
Wu H. Curr Drug Metab. Jan 2018; 19(7): 559-567 Pubmed [8135]
Wu H. Medicine (Baltimore). Sep 2017; 96(35): e7533 Pubmed [9048]
Wu J. Front Psychiatry. Oct 2023; 14: 1257984 Pubmed [13461]
Wu S. Chest. Dec 2022; 162(6): 1360-1372 Pubmed [14126]
Wu T. Biochem Pharmacol. Jan 2017; 124: 29-42 Pubmed [5535]
Wu Y. Pak J Pharm Sci. May 2019; 32(3): 997-1003 Pubmed [10705]
Wu YC. JAMA Psychiatry. Feb 2019 Pubmed, Volltext, DOI [7698]
Wunder LC. ISME J. Dec 2021; 15(12): 3587-3604 Pubmed [12592]
Wungwattana M. Transpl Infect Dis. Apr 2017; 19(2) Pubmed [7043]
Wustrow I. Naunyn Schmiedebergs Arch Pharmacol. Jun 2012; 385(6): 633-9 Pubmed [11159]
Wuttke H. Dtsch Med Wochenschr. Apr 2004; 129(15): 831-5 Pubmed [834]
Wutzler A. J Electrocardiol. Jan 2018; 51(2): 170-174 Pubmed [7796]
www.drug-interaction.com [702]
www.GENEMEDRX.COM, P450 Drug Interactions, Created and maintained by Jessica Oesterheld, Contributing Editors: David N. Osser, M.D, Neil B. Sandson, M.D., Gabriel Eckermann, M.D [2593]
Wyeth (UK). Personal communication, September 2001 [744]
Wynala & Wienkers. Drug Metab Disp 1997;25(10):1211-1214 [1825]
Wynalda MA. Drug Metab Dispos. Jul 2003; 31(7): 878-87 Pubmed [3281]
Wynalda MA. Drug Metab Dispos. Oct 1997; 25(10): 1211-4 Pubmed [370]
Wynalda MA. Drug Metab Dispos. Sep 2000; 28(9): 1014-7 Pubmed [3773]
Wynchank D. Hum Psychopharmacol. Jun 2003; 18(4): 271-5 Pubmed [1936]
Wynn et al. Clinical Manual of Drug Interaction. Principles for medical practice , American Psychiatric Publishing, Washington DC (2009) [2915]
Wynn et al. Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009) [3059]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice , American Psychiatric Publishing, Washington DC (2009 [2942]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice , American Psychiatric Publishing, Washington DC (2009) [2909]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009) [3119]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), p 272 [3126]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), Rifampicin S. 580-581 (Index) [3627]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), S. 161 [3651]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), S. 585 (Index) [3591]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), S. 585 St. John´s wort (Index) [3676]
Wynn GH. Psychosomatics. Jan 2005; 46(1): 79-87 Pubmed [5270]
Xiang Q. J Clin Pharmacol. Jun 2010; 50(6): 659-66 Pubmed [194]
Xiao F. Arch Pharm (Weinheim). Dec 2020; : e2000298 Pubmed [9817]
Xiao JJ. Clin Transl Sci. Jan 2019; 12(1): 58-65 Pubmed [13768]
Xie C. Pediatr Dermatol. Mar 2016; 33(2): e114-20 Pubmed [8898]
Xie RQ. Int J Cardiol. Apr 2010; 140(2): 255-7 Pubmed [8419]
Xie Y. Nat Med. Jan 2025 Pubmed [13921]
Ximenez JPB. BMC Pharmacol Toxicol. Dec 2019; 20(Suppl 1): 81 Pubmed, Volltext, DOI [10513]
Xin H. Aliment Pharmacol Ther. May 2005; 21(9): 1105-9 Pubmed [4088]
Xiong GL. J Clin Psychopharmacol. Aug 2008; 28(4): 472-3 Pubmed [2001]
Xiong Y. Eur J Drug Metab Pharmacokinet. Apr 2016; 41(2): 117-24 Pubmed [14224]
Xu BB. Pharmazie. Jan 2014; 69(1): 43-7 Pubmed [4383]
Xu H. Chirality. Mar 2007; 19(3): 163-70 Pubmed [7447]
Xu H. Conn Med. Sep 2001; 65(9): 527-9 Pubmed [5813]
Xu H. J Clin Pathol. Nov 2014; 67(11): 999-1005 Pubmed, Volltext, DOI [7084]
Xu M. Pharmacotherapy. Mar 2021; 41(3): 277-290 Pubmed [11608]
Xu Q. Front Cell Dev Biol. Jul 2020; 8: 454 Pubmed [11383]
Xu R. Eur J Clin Pharmacol. Jun 2018; 74(6): 755-765 Pubmed [5125]
Xu RA. Pharmazie. May 2013; 68(5): 365-8 Pubmed [353]
Xu WJ. Neuropsychiatr Dis Treat. Apr 2016; 12: 781-3 Pubmed [11605]
Xu Y. CNS Drugs. May 2019; 33(5): 513-522 Pubmed [13527]
Xu ZH. Br J Clin Pharmacol. Sep 1999; 48(3): 416-23 Pubmed [13706]
Xu ZQ. BMJ Open. Mar 2017; 7(3): e013053 Pubmed, Volltext, DOI [8496]
Xue FS. Anesth Analg. Jun 1998; 86(6): 1322-7 Pubmed [7570]
Xue W. Clin Pharmacol Drug Dev. Nov 2021; 10(11): 1316-1324 Pubmed [12179]
Yabuki Y. Pharmacology. Jan 2017; 99(3-4): 160-171 Pubmed [9927]
Yafi FA. Sex Med Rev. Apr 2018; 6(2): 242-252 Pubmed [7644]
Yager N. BMJ Case Rep. Jun 2015; 2015 Pubmed, Volltext, DOI [9546]
Yagi T. Br J Clin Pharmacol. Feb 2023; 89(2): 887-897 Pubmed [12769]
Yagi T. Drug Metab Pharmacokinet. Jan 2012; 27(2): 248-54 Pubmed [13030]
Yagi Y. Toxicol Appl Pharmacol. Nov 2014; 281(1): 39-47 Pubmed [10890]
Yakiwchuk EM. Ann Pharmacother. May 2008; 42(5): 698-703 Pubmed [6426]
Yamada A. Pharmacogenet Genomics. Sep 2011; 21(9): 523-30 Pubmed [12101]
Yamada K. J Clin Psychopharmacol. Aug 2005; 25(4): 398-9 Pubmed [13657]
Yamada S. Drug Metab Dispos. Aug 2010; 38(8): 1314-21 Pubmed [348]
Yamada S. Ther Drug Monit. Dec 2009; 31(6): 764-8 Pubmed [2975]
Yamaguchi H. Eur J Pediatr. Dec 2014; 173(12): 1631-4 Pubmed [4876]
Yamaguchi T. J Smooth Muscle Res. Oct 2005; 41(5): 247-56 Pubmed [5073]
Yamama Y. Life Sci. Oct 2010; 87(17-18): 565-71 Pubmed [9729]
Yamamoto F. Jpn J Antibiot. Feb 2004; 57(1): 124-33 Pubmed [6040]
Yamamoto K. Ann Pharmacother. Oct 1997; 31(10): 1261-2 Pubmed [5234]
Yamamoto T. Epilepsia Open. Jun 2020; 5(2): 274-284 Pubmed, Volltext, DOI [9177]
Yamamoto T. J Med Toxicol. Jan 2019; 15(1): 4-11 Pubmed, Volltext, Springer [8040]
Yamamoto T. Proc Soc Exp Biol Med. Dec 2000; 225(3): 200-6 Pubmed [5057]
Yamamoto T. Xenobiotica. Aug 2003; 33(8): 823-39 Pubmed [32]
Yamamoto Y. Drug Metab Pharmacokinet. Jun 2015; 30(3): 214-20 Pubmed [9254]
Yamamoto Y. Epilepsy Behav. May 2014; 34: 124-6 Pubmed [9292]
Yamamoto Y. Eur J Clin Pharmacol. Oct 2014; 70(10): 1203-10 Pubmed [9424]
Yamamoto Y. Jpn J Infect Dis. Dec 2000; 53(6): 244-5 Pubmed [7102]
Yamamoto Y. Ther Drug Monit. Apr 2015; 37(2): 229-35 Pubmed [9298]
Yamamoto Y. Ther Drug Monit. Feb 2017; 39(1): 55-61 Pubmed [9407]
Yamamoto Y. Ther Drug Monit. Jun 2013; 35(3): 305-12 Pubmed [9435]
Yamanaka K. J Pharm Sci. Nov 1996; 85(11): 1234-7 Pubmed [13238]
Yamaori S. Biochem Pharmacol. Jun 2010; 79(11): 1691-8 Pubmed [7508]
Yamaori S. Drug Metab Dispos. Nov 2011; 39(11): 2049-56 Pubmed [7510]
Yamaori S. Life Sci. Apr 2011; 88(15-16): 730-6 Pubmed [7516]
Yamaori S. Life Sci. Sep 2015; 136: 87-93 Pubmed [7565]
Yamashita S. Pharmacology. Jun 1997; 54(6): 319-27 Pubmed [9436]
Yamaya M. Nihon Kokyuki Gakkai Zasshi. Jan 2002; 40(1): 3-10 Pubmed [3794]
Yamazaki H. Chem Res Toxicol. Jun 1998; 11(6): 659-65 Pubmed [4673]
Yamazaki H. Drug Metab Dispos. Jun 2001; 29(6): 794-7 Pubmed [11990]
Yamazaki H. Drug Metab Dispos. Nov 1998; 26(11): 1053-7 Pubmed [434]
Yamazaki S. Drug Metab Dispos. Aug 2018; 46(8): 1200-1211 Pubmed [7221]
Yamazaki T. Clin Pharmacol Drug Dev. Jan 2017; 6(1): 66-75 Pubmed, Volltext, DOI [7617]
Yamreudeewong W. Drug Saf. Jan 2003; 26(6): 421-38 Pubmed [4570]
Yan JH. J Clin Pharmacol. Nov 2006; 46(11): 1250-8 Pubmed [3444]
Yan KH. Oncol Rep. Sep 2013; 30(3): 1497-505 Pubmed [3955]